Radiopharm Theranostics Signs Supply Agreement With Siemens Healthineers For RAD101 In U.S. Phase 3 Trial After Phase 2b Shows 90% Concordance With MRI In Brain Metastases

Benzinga Newsdesk www.benzinga.com Positive 94.6%

Neg 0% Neu 0% Pos 94.6%

Comments

No comments yet. Be the first!